Class II · Moderate risk
Teva Hydroxyzine Pamoate Capsules
CGMP Deviations: Hydroxyzine Pamoate Capsules, USP, 25 mg were manufactured using an unapproved material: API was incorrectly released for use in manufacturing.
National Drug Code
Is NDC 0555-0323-02 recalled?
Hydroxyzine Pamoate · 100 CAPSULE in 1 BOTTLE (0555-0323-02)
Yes — this exact package was recalled
1 FDA recall names the code 0555-0323-02 directly. A recall still applies to particular lot numbers — compare the lot on your package with the FDA notice below, and talk to your pharmacist before stopping a prescribed medication.
- Active ingredient
- Hydroxyzine Pamoate
- Strength
- HYDROXYZINE PAMOATE 25 mg/1
- Form
- Capsule · Oral
- Labeler
- Teva Pharmaceuticals USA, Inc.
- Type
- Human Prescription Drug
- Product code
- 0555-0323
Recalls naming this package
Where to find this code. The NDC is printed on the pharmacy label and on the manufacturer's carton, usually as three groups of digits after “NDC”. The last group is the package size — two bottles of the same medicine can differ only in that group, and a recall may cover one but not the other.
Other recalled products from this labeler
- 0555-0972 Dextroamphetamine Saccharate, Amphetamine Aspartate, Dextroamphetamine Sulfate and Amphetamine Sulfate 4
- 0555-9123 Jolessa 3
- 0555-0324 Hydroxyzine Pamoate 2
- 0555-0777 Dextroamphetamine Saccharate, Amphetamine Aspartate, Dextroamphetamine Sulfate and Amphetamine Sulfate 2
- 0555-0808 See recall 2
- 0555-0899 Estradiol 2
Free recall alerts
Know the day your medication is recalled
Tell us what you take. When FDA posts a recall announcement or classifies a recall for one of your medications, we email you in plain English, with what to check. No account needed.